Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.
2.

Cortisol-induced immune suppression by a blockade of lymphocyte egress in traumatic brain injury.

Dong T, Zhi L, Bhayana B, Wu MX.

J Neuroinflammation. 2016 Aug 25;13(1):197. doi: 10.1186/s12974-016-0663-y.

3.

The impact of RGS and other G-protein regulatory proteins on Gαi-mediated signaling in immunity.

Kehrl JH.

Biochem Pharmacol. 2016 Aug 15;114:40-52. doi: 10.1016/j.bcp.2016.04.005. Epub 2016 Apr 9. Review.

PMID:
27071343
4.

Gαi2 and Gαi3 Differentially Regulate Arrest from Flow and Chemotaxis in Mouse Neutrophils.

Kuwano Y, Adler M, Zhang H, Groisman A, Ley K.

J Immunol. 2016 May 1;196(9):3828-33. doi: 10.4049/jimmunol.1500532. Epub 2016 Mar 14.

5.

CXCR3 in carcinoma progression.

Ma B, Khazali A, Wells A.

Histol Histopathol. 2015 Jul;30(7):781-92. doi: 10.14670/HH-11-594. Epub 2015 Feb 9. Review.

6.

Implications of non-canonical G-protein signaling for the immune system.

Boularan C, Kehrl JH.

Cell Signal. 2014 Jun;26(6):1269-82. doi: 10.1016/j.cellsig.2014.02.010. Epub 2014 Feb 28. Review.

7.

G proteins Gαi1/3 are critical targets for Bordetella pertussis toxin-induced vasoactive amine sensitization.

Diehl SA, McElvany B, Noubade R, Seeberger N, Harding B, Spach K, Teuscher C.

Infect Immun. 2014 Feb;82(2):773-82. doi: 10.1128/IAI.00971-13. Epub 2013 Dec 9.

8.

The essential role of Giα2 in prostate cancer cell migration.

Zhong M, Clarke S, Vo BT, Khan SA.

Mol Cancer Res. 2012 Oct;10(10):1380-8. doi: 10.1158/1541-7786.MCR-12-0219. Epub 2012 Aug 30.

9.
10.

Altered CXCR3 isoform expression regulates prostate cancer cell migration and invasion.

Wu Q, Dhir R, Wells A.

Mol Cancer. 2012 Jan 11;11:3. doi: 10.1186/1476-4598-11-3.

11.

Pharmacological characterization of a small-molecule agonist for the chemokine receptor CXCR3.

Scholten DJ, Canals M, Wijtmans M, de Munnik S, Nguyen P, Verzijl D, de Esch IJ, Vischer HF, Smit MJ, Leurs R.

Br J Pharmacol. 2012 Jun;166(3):898-911. doi: 10.1111/j.1476-5381.2011.01648.x.

12.

FTY720 blocks egress of T cells in part by abrogation of their adhesion on the lymph node sinus.

Zhi L, Kim P, Thompson BD, Pitsillides C, Bankovich AJ, Yun SH, Lin CP, Cyster JG, Wu MX.

J Immunol. 2011 Sep 1;187(5):2244-51. doi: 10.4049/jimmunol.1100670. Epub 2011 Jul 25.

13.

Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3.

Struyf S, Salogni L, Burdick MD, Vandercappellen J, Gouwy M, Noppen S, Proost P, Opdenakker G, Parmentier M, Gerard C, Sozzani S, Strieter RM, Van Damme J.

Blood. 2011 Jan 13;117(2):480-8. doi: 10.1182/blood-2009-11-253591. Epub 2010 Oct 27.

14.

Variations in Gnai2 and Rgs1 expression affect chemokine receptor signaling and the organization of secondary lymphoid organs.

Hwang IY, Park C, Harrision KA, Huang NN, Kehrl JH.

Genes Immun. 2010 Jul;11(5):384-96. doi: 10.1038/gene.2010.27. Epub 2010 May 27.

15.

Reciprocal function of Galphai2 and Galphai3 in graft-versus-host disease.

Jin YZ, Thompson BD, Zhou ZY, Fu Y, Birnbaumer L, Wu MX.

Eur J Immunol. 2008 Jul;38(7):1988-98. doi: 10.1002/eji.200737738.

16.

Requirement of Galphai in thymic homing and early T cell development.

Jin Y, Wu MX.

Mol Immunol. 2008 Jul;45(12):3401-10. doi: 10.1016/j.molimm.2008.04.007. Epub 2008 May 23.

17.

The chemokine receptor CXCR3 is degraded following internalization and is replenished at the cell surface by de novo synthesis of receptor.

Meiser A, Mueller A, Wise EL, McDonagh EM, Petit SJ, Saran N, Clark PC, Williams TJ, Pease JE.

J Immunol. 2008 May 15;180(10):6713-24.

18.

Chemokine and cytokine mediated loss of regulatory T cells in lymph nodes during pathogenic simian immunodeficiency virus infection.

Qin S, Sui Y, Soloff AC, Junecko BA, Kirschner DE, Murphey-Corb MA, Watkins SC, Tarwater PM, Pease JE, Barratt-Boyes SM, Reinhart TA.

J Immunol. 2008 Apr 15;180(8):5530-6.

Supplemental Content

Support Center